Exopharm Limited Stock price

Equities

EX1

AU0000030975

Biotechnology & Medical Research

Market Closed - Australian S.E. 08:10:45 2023-10-01 pm EDT 5-day change 1st Jan Change
0.011 AUD +10.00% Intraday chart for Exopharm Limited -.--% -.--%
Sales 2022 4.21M 2.74M Sales 2023 3.39M 2.21M Capitalization 3.52M 2.29M
Net income 2022 -10M -6.51M Net income 2023 -7M -4.56M EV / Sales 2022 4.6 x
Net cash position 2022 1.1M 719K Net cash position 2023 109K 71.19K EV / Sales 2023 1 x
P/E ratio 2022
-2.03 x
P/E ratio 2023
-0.22 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 61.79%
More Fundamentals * Assessed data
Dynamic Chart
1 day+10.00%
6 months+10.00%
More quotes
1 year
0.01
Extreme 0.008
0.02
3 years
0.01
Extreme 0.008
1.00
5 years
0.01
Extreme 0.008
1.00
10 years
0.01
Extreme 0.008
1.00
More quotes
Managers TitleAgeSince
Founder - 12-12-31
Corporate Officer/Principal 66 20-09-14
Corporate Secretary 53 21-09-29
Members of the board TitleAgeSince
Chairman - 23-06-21
Founder - 12-12-31
Director/Board Member 43 23-02-21
More insiders
Exopharm Limited is an Australia-based company, which is involved in advancing Genetic Medicines and other exosome-based medicines using exosomes or extracellular vesicles (EVs) as a chassis for improved and non-viral drug delivery. The Company invests in biopharmaceutical drug development. The Company is engaged in exosome technology and holds a portfolio of intellectual property and know-how related to exosomes and the manufacture of exosomes. The Company's exosome technologies solve needs for the success of exosome medicines, LEAP manufacturing technology, LOAD API loading technologies and EVPS tropism technologies. The Company is making its proprietary technologies available to pharmaceutical and biotechnology companies that want to harness exosome delivery for their own products.
Calendar
More about the company
  1. Stock
  2. Equities
  3. Stock Exopharm Limited - Australian S.E.